Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Randomized Controlled Trials Research Studies Patient Care Regulatory Approval Phase 2 Trials Randomized Trials Regulatory Affairs

First Randomized Trial Finds Ketogenic Diet Improves Metabolic Markers and Shows Early Psychiatric Signals in Psychotic Disorders

The results point to ketosis-linked metabolic gains with early psychiatric and cognitive signals that require larger, controlled trials.

Moderna Repositions as Broad mRNA Company After Investor Day Rally

Pilot Trial Finds Daily Probiotics Produce Modest Drop in Depression and Anxiety in Older Adults

Novo Nordisk Confirms Cyberattack That Copied Clinical Trial Data

Lilly Wins Exclusive License to Ascidian RNA Exon-Editing Platform for Kidney Diseases

Mount Sinai Study Links Autoantibodies to Long COVID in a Subset

MediWound Posts Weak Q1 but Reaffirms 2026 Revenue Target as BARDA Deal and Factory Upgrades Drive H2 Plan

Mass General Brigham Study Finds One in Six COVID Patients Developed Long COVID

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

Macrophage Cell Therapy Raises Four‑Year Transplant‑Free Survival in Cirrhosis

Coached Lifestyle Program Slows Frailty and Improves Cognition in Older Adults

Nicotine E-Cigarettes Tripled Short-Term Quit Rates in U.S. Placebo-Controlled Trial

Single Psilocybin Dose Shows Rapid Antidepressant Effects in Swedish Phase II Trial

Novo Nordisk’s Wegovy Pill Shows Strong Results, Reinforcing Stock Rebound

Ajax Health Puts $60 Million Into UroMems to Advance Smart Urinary Sphincter

Odyssey Therapeutics Shares Rise 11% in Nasdaq Debut After $279 Million IPO

Novo Nordisk Lifts 2026 Outlook on Surging Wegovy Pill Uptake

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Krystal Biotech Reports Strong Q1 on VYJUVEK, Readies Wider Launches

Inspire Medical Cuts 2026 Outlook as Coding Snags and Medicare AI Pilot Slow Procedures